Q2 2024 Holdings
Filed 2024-07-10 | 5 holdings | $91.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Centessa Pharmaceuticals plc(CNTA) | Ordinary Shares | 152309100 | $35.5M | 3,931,818 | 38.8% |
| Kyverna Therapeutics, Inc.(KYTX) | Common Stock | 501976104 | $33.9M | 4,523,924 | 37.1% |
| Dyne Therapeutics, Inc.(DYN) | Common Stock | 26818M108 | $14.4M | 407,499 | 15.7% |
| Allogene Therapeutics, Inc.(ALLO) | Common Stock | 019770106 | $4.2M | 1,798,163 | 4.6% |
| Kronos Bio, Inc.(KRON1USD) | Common Stock | 50107A104 | $3.4M | 2,765,314 | 3.8% |